
Patient & public involvement (PPI)
Patients are at the heart of our research. Learn how your involvement shapes the FREEDOM trial.
Designed with patients, not just for them
The National Institute for Health and Care Research (NIHR) defines public involvement in research as research being carried out ‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them.
This has been central to the design of the FREEDOM trial.
Our PPI journey
How patient feedback has guided us from the very beginning
Before funding
Collected experiences and patient journeys from 36 women to understand how current treatments and care pathways could be improved
Before funding
Collected experiences and patient journeys from 36 women to understand how current treatments and care pathways could be improved
During study design
Recruited 14 PPI group members who provided feedback on Callavid® prototype and trial design
Co-design
PPI members co-designed questionnaires, patient-facing documents, interview questions, and this website
Trial starts
As of April 14th 2026, patient recruitment began.
Continued support
PPI members continue to provide input in Trial Steering Committee (TSC) and Trial Management Group (TMG).
Dissemination
Future plans for sharing study results via conferences and publications.
How patients have shaped this trial
Patients and the public have been actively involved as co-researchers across several critical areas of the FREEDOM trial design and implementation.
Questionnaires & documents
Feedback on wording, images, and questionnaires completed during participant visits to UHCW
Instructional video
Feedback on the IFU (Instructions for Use) video content and clarity
Logo selection
Selection of the FREEDOM trial logo and visual branding
Website design
Co-design of this trial website to ensure it meets participant needs
Patient information sheet (PIS)
Communication regarding Round 3 and overall PIS clarity
Sample collection
Input on collection of used Callavid® devices and pads to assess progesterone levels
Product feedback
Initial feedback on the Callavid® product design and usability
Reimbursement
Input on participant reimbursement and blood sample procedures
Topic guide questions
Development of interview questions for participants after completing the trial
Want to get involved in our PPI group?
We welcome new members who want to help shape this research and improve women’s health outcomes.
Email us: freedomstudyoffice@uhcw.nhs.uk